# Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL

> **NCT05588128** · — · RECRUITING · sponsor: **National Cancer Institute (NCI)** · enrollment: 350 (estimated)

## Conditions studied

- Prostate Cancer
- Biochemically Recurrent

## Interventions

- **DRUG:** 18F-DCFpyL

## Key facts

- **NCT ID:** NCT05588128
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-21
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05588128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05588128, "Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05588128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*